Table 3 Two by two comparison of cell viability (MTT assay) in study groups after different days (with Post Hoc tests) (* indicates significant differences)
| Â | Groups (N) | Mean Difference (SD) | P-value | |
|---|---|---|---|---|
Day 1 | MTT no LLLI | MTT single dose LLLI (7) | -33.59 (13.89) | 0.065 |
MTT double dose LLLI (7) | -64.78 (13.89)* | 0.001 | ||
MTT single dose LLLI | MTT no LLLI (7) | 33.59 (13.89) | 0.065 | |
MTT double dose LLLI (7) | -31.19 (13.89) | 0.090 | ||
MTT double dose LLLI | MTT no LLLI (7) | 64.78 (13.89) * | 0.001 | |
MTT single dose LLLI (7) | 31.19 (13.89) | 0.090 | ||
Day 7 | MTT no LLLI | MTT single dose LLLI (7) | -41.96 (24.48) | 0.227 |
MTT double dose LLLI (7) | -73.67 (24.48) * | 0.020 | ||
MTT single dose LLLI | MTT no LLLI (7) | 41.96 (24.48) | 0.227 | |
MTT double dose LLLI (7) | -31.70 (24.48) | 0.416 | ||
MTT double dose LLLI | MTT no LLLI (7) | 73.67 (24.48) * | 0.020 | |
MTT single dose LLLI (7) | 31.70 (24.48) | 0.416 | ||
Day 14 | MTT no LLLI | MTT single dose LLLI (7) | -82.96 (12.33) * | 0.000 |
MTT double dose LLLI (7) | -102.14 (12.33) * | 0.000 | ||
MTT single dose LLLI | MTT no LLLI (7) | 82.96* (12.33) | 0.000 | |
MTT double dose LLLI (7) | -19.18 (12.33) | 0.290 | ||
MTT double dose LLLI | MTT no LLLI (7) | 102.14 (12.33) * | 0.000 | |
MTT single dose LLLI (7) | 19.18 (12.33) | 0.290 | ||